Nuvectis Pharma, Inc. (NASDAQ:NVCT) currently has 12 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 30 Sep, 2025 | 698,708 | 31,903 | 4.78% | $4,206,222.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 685,337 | 42,355 | 6.59% | $4,125,728.00 |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 30 Sep, 2025 | 405,621 | 32,904 | 8.83% | $2,441,838.00 |
| BALDWIN WEALTH PARTNERS LLC/MA | 30 Sep, 2025 | 350,461 | 0 | 0.00% | $2,109,775.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 325,733 | 40,401 | 14.16% | $1,961,379.00 |
| Occam Crest Management LP | 30 Sep, 2025 | 290,000 | 290,000 | 0.00% | $1,745,800.00 |
| STATE STREET CORP | 30 Sep, 2025 | 136,716 | 23,137 | 20.37% | $823,030.00 |
| NORTHERN TRUST CORP | 30 Sep, 2025 | 106,641 | -3,176 | -2.89% | $641,979.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 30 Sep, 2025 | 90,879 | 45,605 | 100.73% | $547,092.00 |
| OPPENHEIMER & CO INC | 30 Sep, 2025 | 69,066 | 0 | 0.00% | $415,777.00 |
| GOLDMAN SACHS GROUP INC | 30 Sep, 2025 | 45,163 | 45,163 | 0.00% | $271,881.00 |
| RENAISSANCE TECHNOLOGIES LLC | 30 Sep, 2025 | 42,800 | -200 | -0.47% | $257,656.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 30 Sep, 2025 | 37,982 | 0 | 0.00% | $228,652.00 |
| ROYAL BANK OF CANADA | 30 Sep, 2025 | 31,006 | -226 | -0.72% | $186,000.00 |
| Bank of New York Mellon Corp | 30 Sep, 2025 | 28,071 | 832 | 3.05% | $168,984.00 |
| JANE STREET GROUP, LLC | 30 Sep, 2025 | 26,278 | 26,278 | 0.00% | $158,194.00 |
| UBS Group AG | 30 Sep, 2025 | 25,469 | 15,211 | 148.28% | $153,323.00 |
| GSA CAPITAL PARTNERS LLP | 30 Sep, 2025 | 23,450 | -15,710 | -40.12% | $141.00 |
| Austin Wealth Management, LLC | 30 Sep, 2025 | 20,125 | 0 | 0.00% | $119,140.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 18,517 | -6,176 | -25.01% | $111,472.00 |